Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FRUQUINTINIB vs GADAVIST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FRUQUINTINIB vs GADAVIST: Safety Overview

Metric FRUQUINTINIB GADAVIST
Total FAERS Reports 2,565 193
Deaths Reported 874 3
Death Rate 34.1% 1.6%
Hospitalizations 753 12
Average Patient Age 63.9 yrs 49.0 yrs
% Female Patients 44.4% N/A
FDA Approval Date Nov 8, 2023 N/A
Manufacturer Takeda Pharmaceuticals America, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A